?-Adrenergic blockade does not prevent polycythemia or decrease in plasma volume in men at 4300 m altitude
| Autor: | M. A. Selland, John T. Reeves, Gail E. Butterfield, R. G. McCullough, R. F. Grover, J. E. Greenleaf, Thomas E. Dahms, Eugene E. Wolfel |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Adult
Male medicine.medical_specialty Physiology Adrenergic beta-Antagonists Blood volume Polycythemia Propranolol Hematocrit Physiology (medical) Hypovolemia Internal medicine Blood plasma medicine Humans Erythropoiesis Orthopedics and Sports Medicine Plasma Volume Hypoxia Erythropoietin Blood Volume Red Cell medicine.diagnostic_test Chemistry Altitude Public Health Environmental and Occupational Health General Medicine Hypoxia (medical) Endocrinology medicine.symptom medicine.drug |
| Zdroj: | European Journal of Applied Physiology. 77:264-270 |
| ISSN: | 1439-6327 1439-6319 |
| DOI: | 10.1007/s004210050331 |
| Popis: | When humans ascend to high altitude (ALT) their plasma volume (PV) and total blood volume (BV) decrease during the first few days. With continued residence over several weeks, the hypoxia-induced stimulation of erythropoietin increases red cell production which tends to restore BV. Because hypoxia also activates the beta-adrenergic system, which stimulates red blood cell production, we investigated the effect of adrenergic beta-receptor inhibition with propranolol on fluid volumes and the polycythemic response in 11 healthy unacclimatized men (21-33 years old exposed to an ALT of 4300 m (barometric pressure 460 Torr) for 3 weeks on Pikes Peak, Colorado. PV was determined by the Evans blue dye method (PV(sub EB)), BV by the carbon monoxide method (BV(sub CO)), red cell volume (RCV)was calculated from hematocrit (Hct) and BV(sub CO), and serum erythropoietin concentration ([EPO]) and reticulocyte count, were also determined. All determinations were made at sea level and after 9-11 (ALT-10) and 9-20 (ALT-20) days at ALT. At sea level and ALT, six men received propranolol (pro, 240 mg/day), and five received a placebo (pla). Effective beta-blockade did not modify the mean (SE) maximal values of [EPO] [pla: 24.9 (3.5) vs pro: 24.5 (1.5) mU/ml] or reticulocyte count [pla: 2.7 (0.7) vs pro: 2.2 (0.5)%]; nor changes in PV(sub EB)[pla: -15.8 (3.8) vs pro: -19.9 (2.8)%], RCV(sub CO) [pla: +7.0 (6.7) vs pro: +10.1 (6.1)%], or BV(sub CO) [pla: -7.3 (2.3) vs pro: -7.1 (3.9)%]. In the absence of weight loss, a redistribution of body water with no net loss is implied. Hence, activation of the beta-adrenergic system did not appear to affect the hypovolemic or polycythemic responses that occurred during 3 weeks at 4300 m ALT in these subjects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink